SCHEMBL8225474

SCHEMBL8225474

IN1CCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18138135 1.00
SCHEMBL3439854 1.00
SCHEMBL29010399 0.96
SCHEMBL141116 0.95
SCHEMBL22959048 0.86
SCHEMBL18249291 0.84
SCHEMBL14392643 0.82
SCHEMBL187564 0.80
SCHEMBL20124361 0.76
SCHEMBL23742215 0.75 ALDH1A1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023227505-A1 LIQUID PHARMACEUTICAL FORMULATIONS OF CNP COMPOUNDS ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) 2023-11-30 WO disclosed
US-11732062-B2 Modification polymerization initiator and method for preparing the same LG CHEM, LTD. 2023-08-22 US disclosed
WO-2023154962-A1 CGAS INHIBITORS AND USES THEREOF SINHA SUBHASH (US) 2023-08-17 WO disclosed
WO-2023150719-A1 ALPHA-METHYLENE AND AMINOMETHYL LACTONES AND LACTAMS FOR TREATMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) PURDUE RESEARCH FOUNDATION (US) 2023-08-10 WO disclosed
WO-2023149982-A1 COMPOUNDS FOR THE TREATMENT OF SARS PURDUE RESEARCH FOUNDATION (US) 2023-08-10 WO disclosed
WO-2023147485-A2 PROTEASOME ENHANCERS AND USES THEREOF BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2023-08-03 WO disclosed
EP-3680229-B1 MODIFICATION POLYMERIZATION INITIATOR AND METHOD FOR PREPARING THE SAME LG CHEMICAL LTD (KR) 2023-08-02 EP disclosed
WO-2023110758-A1 EFFECTIVE DOSES OF CNP CONJUGATES ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) 2023-06-22 WO disclosed
US-20230124390-A1 POLYMER MATERIAL, NANOPARTICLE AND DRUG PREPARED THEREFROM, AND PREPARATION METHOD OF NANOPARTICLE SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) 2023-04-20 US disclosed
WO-2023061294-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 再鼎医药(上海)有限公司 2023-04-20 WO disclosed
WO-2008106130-A2 TERTIARY AMINE SUBSTITUTED PEPTIDES USEFUL AS INHIBITORS OF HCV REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2008-09-04 WO disclosed
WO-2007103260-A1 PHOSPHODIESTERASE 10 INHIBITORS AMGEN INC. (US) 2007-09-13 WO disclosed
WO-2007103370-A2 QUINAZOLINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS AMGEN INC. (US) 2007-09-13 WO disclosed
WO-2007100880-A1 CINNOLINE AND QUINAZOLINE DERIVATES AS PHOSPHODIESTERASE 10 INHIBITORS AMGEN INC. (US) 2007-09-07 WO disclosed
WO-2007098214-A1 CINNOLINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS AMGEN INC. (US) 2007-08-30 WO disclosed
EP-0215238-B1 PROCESS FOR PURIFYING THIOCARBAMYLSULFENAMIDES The B.F. GOODRICH Company (US) 1989-10-11 EP disclosed
EP-0215238-A1 Process for purifying thiocarbamylsulfenamides The B.F. GOODRICH Company (US) 1987-03-25 EP disclosed
US-4639517-A Process for stabilizing thiocarbamylsulfenamides THE B F GOODRICH COMPANY (US) 1987-01-27 US disclosed
US-4632986-A Process for purifying thiocarbamylsulfenamides THE BFGOODRICH COMPANY (US) 1986-12-30 US disclosed
US-3985743-A FROM AN AMINE AND A MONOHALOAMINE WTIH CARBON DISULFIDE IN A BASE THE B. F. GOODRICH COMPANY (US) 1976-10-12 US disclosed